CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2017—Bio SB announced it now offers 25 monoclonal antibodies for IVD applications. Among the new products is a line of reagents for mesothelioma diagnosis, including BAP1, mesothelial cell HBME 1, and caveolin 1.
The company has also launched three new antibodies, alpha-synuclein, amyloid beta, and tau, all used in the diagnosis of Alzheimer and Parkinson disease, and continues to add rabbit monoclonal antibodies, like CD16, CD33, GATA3, HE4, inhibin alpha, LAG-3, langerin, LEF-1, parvalbumin, SMAD4, and STAT6, to its portfolio.
Bio SB, 805-692-2768